Protagonist Therapeutics, Inc. ( PTGX) - Key Metrics

PTGX Revenue per Share metrics
Date Revenue per Share Net Income per Share Operating Cash Flow Free Cash Flow per Share
2026Q2 $3.24 $2.47 $3.32 $3.32
2026Q1 $0.87 $0.06 -$0.75 -$0.76
2025Q4 $0.12 -$0.70 -$0.58 -$0.56
2025Q3 $0.07 -$0.62 -$0.03 -$0.03
2025Q2 $0.09 -$0.55 -$0.45 -$0.47

PTGX Payout ratio and Price per Earnings ratio
Date Payout ratio PE ratio
2026Q2 0% 12.41
2026Q1 0% 453.53
2025Q4 0% -31.64
2025Q3 0% -26.79
2025Q2 0% -25.12

PTGX Free Cash Flow Yield and Dividend Yield
DateFree Cash Flow YieldDividend Yield
2026Q2 2.71% 0%
2026Q1 -0.72% 0%
2025Q4 -0.64% 0%
2025Q3 -0.05% 0%
2025Q2 -0.84% 0%

PTGX

Price: $155.10

52 week price:
50.49
155.10

Earnings Per Share: 1.04 USD

P/E Ratio: 140.26

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 966400

Ebitda: -4.9 million

Market Capitalization: 9.4 billion

Links: